Literature DB >> 3282883

Cardiac nuclear medicine, present status, future hopes as seen from the view of a cardiologist.

P R Lichtlen1.   

Abstract

The present techniques of nuclear medicine that are used in cardiology are critically evaluated. They are used mainly for the assessment of coronary circulation (measurement of regional flow and perfusion), on the determination of left ventricular muscle function (radionuclear ventriculography) and on the study of cardiac metabolism. The last-mentioned technique is unique insofar as (except for magnetic resonance imaging) there is no other method available to analyse myocardial metabolism noninvasively in living man. Of immense practical importance is the diagnosis and quantitation of the abnormal coronary flow and perfusion, as coronary artery disease is one of the major diseases of the Western world. Finally, the value of nuclear imaging techniques is compared with that of other nonnuclear methods. In present-day medicine, with its increasingly high costs, the value of nuclear techniques must be assessed very carefully.

Entities:  

Mesh:

Year:  1988        PMID: 3282883     DOI: 10.1007/bf00256388

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  35 in total

1.  MEASUREMENT OF MYOCARDIAL BLOOD FLOW IN ANIMALS AND MAN BY SELECTIVE INJECTION OF RADIOACTIVE INERT GAS INTO THE CORONARY ARTERIES.

Authors:  R S ROSS; K UEDA; P R LICHTLEN; J R REES
Journal:  Circ Res       Date:  1964-07       Impact factor: 17.367

2.  [Nuclear medicine--quo vadis?].

Authors:  D Emrich
Journal:  Dtsch Med Wochenschr       Date:  1987-10-09       Impact factor: 0.628

Review 3.  Positron tomography and myocardial metabolism: an overview.

Authors:  B E Sobel
Journal:  Circulation       Date:  1985-11       Impact factor: 29.690

4.  Seven-pinhole emission tomography with thallium-201 in patients with prior myocardial infarction.

Authors:  J L Ritchie; D L Williams; J H Caldwell; J R Stratton; G D Harp; R A Vogel; G W Hamilton
Journal:  J Nucl Med       Date:  1981-02       Impact factor: 10.057

5.  [The normal wall segment in coronary stenoses--a postmortal study (author's transl)].

Authors:  H Freudenberg; P R Lichtlen
Journal:  Z Kardiol       Date:  1981-12

6.  [201-thallium stress scintigram in patients with coronary artery disease after administration of the cardioselective betablocker atenolol (author's transl)].

Authors:  J Chlup; H J Engel; P Pretschner; P R Lichtlen
Journal:  Z Kardiol       Date:  1981-06

7.  Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.

Authors:  E M Geltman; J L Smith; D Beecher; P A Ludbrook; M M Ter-Pogossian; B E Sobel
Journal:  Am J Med       Date:  1983-05       Impact factor: 4.965

8.  Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.

Authors:  B E Sobel; E M Geltman; A J Tiefenbrunn; A S Jaffe; J J Spadaro; M M Ter-Pogossian; D Collen; P A Ludbrook
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

9.  Chronic aortic regurgitation: reassessment of the prognostic value of preoperative left ventricular end-systolic dimension and fractional shortening.

Authors:  W G Daniel; W P Hood; A Siart; D Hausmann; U Nellessen; H Oelert; P R Lichtlen
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

10.  Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart.

Authors:  C Steenbergen; M L Hill; R B Jennings
Journal:  Circ Res       Date:  1987-04       Impact factor: 17.367

View more
  1 in total

1.  The contraction fraction (CF) in myocardial studies with technetium-99m-isonitrile (MIBI)--correlations with radionuclide ventriculography and infarct size measured by SPECT.

Authors:  M Clausen; E Henze; A Schmidt; R Weller; R Lietzenmayer; D Hellwig; F Bitter; P Hildebrand; V Hombach; W E Adam
Journal:  Eur J Nucl Med       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.